Author Correction: Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics

Sadal Refae1, Jocelyn Gal2, Patrick Brest3

  • 1University Côte d'Azur, Centre Antoine Lacassagne, Oncopharmacology Unit, Nice, France.

Scientific Reports
|June 13, 2020
PubMed
Summary

This study has been amended. Please refer to the updated version for the most current findings and analysis.